Literature DB >> 13525779

The effect of passage with chloramphenicol upon the behavior of penicillin-resistant feline pneumonitis virus during subsequent passage with penicillin.

J W MOULDER, J RUDA, J I COLON, R M GREENLAND.   

Abstract

Entities:  

Keywords:  CHLORAMPHENICOL/effects; MIYAGAWANELLA/effect of drugs on

Mesh:

Substances:

Year:  1958        PMID: 13525779     DOI: 10.1093/infdis/102.2.186

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  DIRECT AND INDIRECT FLUORESCENT-ANTIBODY TECHNIQUES FOR THE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM-TRACHOMA GROUP OF AGENTS.

Authors:  M R ROSS; E K BORMAN
Journal:  J Bacteriol       Date:  1963-04       Impact factor: 3.490

2.  TYPE-SPECIFIC ANTIGENS IN THE PSITTACOSIS-LYMPHOGRANULOMA VENEREUM GROUP OF ORGANISMS.

Authors:  C E FRASER; D T BERMAN
Journal:  J Bacteriol       Date:  1965-04       Impact factor: 3.490

3.  Plaque reduction technique for demonstrating neutralizing antibodies for Chlamydia.

Authors:  J Banks; B Eddie; M Sung; N Sugg; J Schachter; K F Meyer
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

4.  Demonstration of host-species-specific antigens in Chlamydia psittaci by the plaque-reduction test in L-cell tissue cultures. Preliminary observations.

Authors:  K F Meyer
Journal:  Arch Gesamte Virusforsch       Date:  1970

5.  Clonal analysis of tumorigenesis of bovine adenovirus type 3 and isolation of a nontumorigenic variant.

Authors:  Y Nishibe; T Kimura; Y K Inoue
Journal:  Arch Gesamte Virusforsch       Date:  1970

6.  Application of the single-dose assay technique to psittacosis.

Authors:  J M Riley; W E Campbell; M D Orlando; W N Shirey; W G Dorsey
Journal:  Appl Microbiol       Date:  1967-05

7.  CHANGES IN MOUSE PNEUMONITIS AGENT ASSOCIATED WITH DEVELOPMENT OF RESISTANCE TO CHLORTETRACYCLINE.

Authors:  J W MOULDER; D L NOVOSEL; I I TRIBBY
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.